UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 52.

Santuccione, A C; Merlini, M; Shetty, A; Tackenberg, C; Bali, J; Ferretti, M T; McAfoose, J; Kulic, L; Bernreuther, C; Welt, T; Grimm, J; Glatzel, M; Rajendran, L; Hock, C; Nitsch, R M (2013). Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice. Molecular Psychiatry, 18(3):358-368.

Krasemann, S; Neumann, M E; Geissen, M; Bodemer, W; Kaup, F J; Schulz-Schaeffer, W; Morel, N; Aguzzi, A; Glatzel, M (2010). Preclinical deposition of pathological prion protein in muscle of experimentally infected primates. PLoS ONE, 5(11):e13906.

Ruegger, J; Stoeck, K; Amsler, L; Blaettler, T; Zwahlen, M; Aguzzi, A; Glatzel, M; Hess, K; Eckert, T (2009). A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004. BMC Public Health, 9:18.

Kellner, A; Matschke, J; Bernreuther, C; Moch, H; Ferrer, I; Glatzel, M (2009). Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Annals of Neurology, 65(1):24-31.

Debatin, L; Streffer, J; Geissen, M; Matschke, J; Aguzzi, A; Glatzel, M (2008). Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegenerative Diseases, 5(6):347-354.

Stoeck, K; Hess, K; Amsler, L; Eckert, T; Zimmermann, D R; Aguzzi, A; Glatzel, M (2008). Heightened incidence of sporadic Creutzfeldt-Jakob disease is associated with a shift in clinicopathological profiles. Journal of Neurology, 255(10):1464-1472.

Galliciotti, G; Glatzel, M; Kinter, J; Kozlov, S V; Cinelli, P; Rülicke, T; Sonderegger, P (2007). Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies. American Journal of Pathology, 170(4):1305-1313.

Lötscher, M; Recher, M; Lang, K S; Navarini, A; Hunziker, L; Santimaria, R; Glatzel, M; Schwarz, P; Böni, J; Zinkernagel, R M (2007). Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS ONE, 2(11):e1158.

Sigurdson, C J; Manco, G J; Schwarz, P; Liberski, P; Hoover, E A; Hornemann, S; Polymenidou, M; Miller, M W; Glatzel, M; Aguzzi, A (2006). Strain fidelity of chronic wasting disease upon murine adaptation. Journal of Virology, 80(24):12303-12311.

Landolt, H P; Glatzel, M; Blättler, T; Achermann, P; Roth, C; Mathis, J; Weis, J; Tobler, I; Aguzzi, A; Bassetti, C L (2006). Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology, 66(9):1418-1424.

Vogelgesang, S; Glatzel, M; Walker, L C; Kroemer, H K; Aguzzi, A; Warzok, R W (2006). Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease. Acta Neuropathologica, 111(5):436-443.

Schoch, G; Seeger, H; Bogousslavsky, J; Tolnay, M; Janzer, R C; Aguzzi, A; Glatzel, M (2006). Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Medicine, 3(2):e14.

Aguzzi, A; Glatzel, M (2006). Prion infections, blood and transfusions. Nature Reviews. Neurology, 2(6):321-329.

Polymenidou, M; Stoeck, K; Glatzel, M; Vey, M; Bellon, A; Aguzzi, A (2005). Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurology, 4(12):805-814.

Glatzel, M; Mohajeri, M H; Poirier, R; Nitsch, R M; Schwarz, Petra; Lu, B; Aguzzi, A (2005). No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis. Journal of General Virology, 8(6):1861-1867.

Ladogana, A; Puopolo, M; Croes, E A; Budka, H; Jarius, C; Collins, S; Klug, G M; Sutcliffe, T; Giulivi, A; Alperovitch, A; Delasnerie-Laupretre, N; Brandel, J-P; Poser, S; Kretzschmar, H A; Rietveld, I; Mitrova, E; Cuesta, J de Pedro; Martinez-Martin, P; Glatzel, M; Aguzzi, A; Knight, R; Ward, H; Pocchiari, M; van Duijn, C M; Will, R G; Zerr, I (2005). Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology, 64(9):1586-1591.

Glatzel, M; Stoeck, K; Seeger, H; Lührs, T; Aguzzi, A (2005). Human prion diseases: molecular and clinical aspects. Archives of Neurology, 62(4):545-552.

Russmann, H; Vingerhoets, F; Miklossy, J; Maeder, P; Glatzel, M; Aguzzi, A; Bogousslavsky, J (2005). Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging. Journal of Neurology, 252(3):338-342.

Pocchiari, M; Puopolo, M; Croes, E A; Budka, H; Gelpi, E; Collins, S; Lewis, V; Sutcliffe, T; Guilivi, A; Delasnerie-Laupretre, N; Brandel, J-P; Alperovitch, A; Zerr, I; Poser, S; Kretzschmar, H A; Ladogana, A; Rietvald, I; Mitrova, E; Martinez-Martin, P; de Pedro-Cuesta, J; Glatzel, M; Aguzzi, A; Cooper, S; Mackenzie, J; van Duijn, C M; Will, R G (2004). Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain: A Journal of Neurology, 127(10):2348-2359.

Prinz, M; Montrasio, F; Furukawa, H; van der Haar, M E; Schwarz, Petra; Rülicke, T; Giger, O T; Häusler, K G; Perez, D; Glatzel, M; Aguzzi, A (2004). Intrinsic resistance of oligodendrocytes to prion infection. Journal of Neuroscience, 24(26):5974-5981.

Glatzel, M; Giger, O; Braun, N; Aguzzi, A (2004). The peripheral nervous system and the pathogenesis of prion diseases. Current Molecular Medicine, 4(4):355-359.

Aguzzi, A; Glatzel, M (2004). vCJD tissue distribution and transmission by transfusion--a worst-case scenario coming true? Lancet, 363(9407):411-412.

Glatzel, M; Giger, Olivier; Seeger, H; Aguzzi, A (2004). Variant Creutzfeldt-jakob disease: between lymphoid organs and brain. Trends in Microbiology, 12(2):51-53.

Kovacs, G G; Lindeck-Pozza, E; Chimelli, L; Araújo, A Q C; Gabbai, A A; Ströbel, T; Glatzel, M; Aguzzi, A; Budka, H (2004). Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Annals of Neurology, 55(1):121-125.

Rossetti, A O; Bogousslavsky, J; Glatzel, M; Aguzzi, A (2004). Mimicry of variant Creutzfeldt-Jakob disease by sporadic Creutzfeldt-Jakob disease: importance of the pulvinar sign. Archives of Neurology, 61(3):445-446.

Glatzel, M; Ott, P M; Linder, T; Gebbers, J O; Gmür, A; Wüst, W; Huber, G; Moch, H; Podvinec, M; Stamm, B; Aguzzi, A (2003). Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurology, 2(12):757-763.

Glatzel, M; Abela, E; Maissen, M; Aguzzi, A (2003). Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. New England Journal of Medicine, 349(19):1812-1820.

Prinz, M; Heikenwalder, M; Junt, T; Schwarz, Petra; Glatzel, M; Heppner, F L; Fu, Y X; Lipp, M; Aguzzi, A (2003). Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature, 425(6961):957-962.

Prinz, M; Huber, G; Macpherson, A J S; Heppner, F L; Glatzel, M; Eugster, H P; Wagner, N; Aguzzi, A (2003). Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. American Journal of Pathology, 162(4):1103-1111.

Rossetti, A O; Glatzel, M; Aguzzi, A; Janzer, R; Bogousslavsky, J (2003). Clinical and radiological mimicry of vCJD in a valine homozygous PrP(Sc) type 1 sCJD patient. Journal of Neurology, 250(4):491-493.

Aguzzi, A; Heppner, F L; Heikenwalder, M; Prinz, M; Mertz, K; Seeger, H; Glatzel, M (2003). Immune system and peripheral nerves in propagation of prions to CNS. British Medical Bulletin, 66(1):141-159.

Künzi, V; Glatzel, M; Nakano, M Y; Greber, U F; Van Leuven, F; Aguzzi, A (2002). Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau. Journal of Neuroscience, 22(17):7471-7477.

Glatzel, M; Pekarik, V; Lührs, T; Dittami, J; Aguzzi, A (2002). Analysis of the prion protein in primates reveals a new polymorphism in codon 226 (Y226F). Biological Chemistry, 383(6):1021-1025.

Glatzel, M; Rogivue, C; Ghani, A; Streffer, J R; Amsler, L; Aguzzi, A (2002). Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet, 360(9327):139-141.

Glatzel, M; Gottwein, J; Aguzzi, A (2002). Prionen als Motor der transmissiblen spongiformen Enzephalopathien. Schweizer Archiv für Tierheilkunde, 144(12):633-638.

Glatzel, M; Brandner, S; Klein, M A; Horstmann, S K; Aguzzi, A (2002). Prions--role of the peripheral nervous system. Virus Research, 82(1-2):53.

Rogivue, C; Gottwein, J; Aguzzi, A; Glatzel, M (2002). Transmissible spongiforme Enzephalopathien beim Menschen. Schweizer Archiv für Tierheilkunde, 144(12):685-690.

Glatzel, M; Aguzzi, A (2001). Sympathetic prions. The Scientific World Journal, 1:555-556.

Aguzzi, A; Glatzel, M; Montrasio, F; Prinz, M; Heppner, F L (2001). Interventional strategies against prion diseases. Nature Reviews. Neuroscience, 2(10):745-749.

Glatzel, M; Aguzzi, A (2001). The shifting biology of prions. Brain Research Reviews, 36(2-3):241-248.

Glatzel, M; Heppner, F L; Albers, K M; Aguzzi, A (2001). Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron, 31(1):25-34.

Maissen, M; Roeckl, C; Glatzel, M; Goldmann, W; Aguzzi, A (2001). Plasminogen binds to disease-associated prion protein of multiple species. Lancet, 357(9273):2026-2028.

Aguzzi, A; Brandner, S; Fischer, M B; Furukawa, H; Glatzel, M; Hawkins, C; Heppner, F L; Montrasio, F; Navarro, B; Parizek, P; Pekarik, V; Prinz, M; Raeber, A J; Röckl, C; Klein, M A (2001). Spongiform encephalopathies: insights from transgenic models. Advances in Virus Research, 56:313-352.

Brandner, S; Klein, M A; Frigg, R; Pekarik, V; Parizek, P; Raeber, A; Glatzel, M; Schwarz, P; Rülicke, T; Weissmann, C; Aguzzi, A (2000). Neuroinvasion of prions: insights from mouse models. Experimental Physiology, 85(6):705-712.

Glatzel, M; Aguzzi, A (2000). PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. Journal of General Virology, 81(11):2813-2821.

Montrasio, F; Frigg, R; Glatzel, M; Klein, M A; Mackay, F; Aguzzi, A; Weissmann, C (2000). Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science, 288(5469):1257-1259.

Glatzel, M; Aguzzi, A (2000). Peripheral pathogenesis of prion diseases. Microbes and Infection, 2(6):613-619.

Glatzel, M; Flechsig, E; Navarro, B; Klein, M A; Paterna, J C; Büeler, H; Aguzzi, A (2000). Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 97(1):442-447.

Hergersberg, M; Glatzel, M; Capone, A; Achermann, S; Hagmann, A; Fischer, J; Ersch, J; Aguzzi, A; Boltshauser, E (2000). Deletions in the spinal muscular atrophy gene region in a newborn with neuropathy and extreme generalized muscular weakness. European Journal of Paediatric Neurology, 4(1):35-38.

Glatzel, M; Klein, M A; Brandner, S; Aguzzi, A (2000). Prions: from neurografts to neuroinvasion. Archives of virology. Supplementum, 16(3):3-12.

Aguzzi, A; Klein, M A; Montrasio, F; Pekarik, V; Brandner, S; Furukawa, H; Käser, P; Röckl, C; Glatzel, M (2000). Prions: pathogenesis and reverse genetics. Annals of the New York Academy of Sciences, 920:140-157.

Maddalena, A S; Hainfellner, J A; Hegi, M E; Glatzel, M; Aguzzi, A (1999). No complementation between TP53 or RB-1 and v-src in astrocytomas of GFAP-v-src transgenic mice. Brain Pathology, 9(4):627-637.

This list was generated on Sun Jul 23 17:00:48 2017 CEST.